bioRxiv Science⌕ Search

Biology subjects

Freitag, R.

Publications and source records attributed to Freitag, R..

3 recordsLinked to original sources

PanRes: A database of latent and acquired antimicrobial resistance allowing 3D-based protein homology search

Antimicrobial resistance databases are central to genomic surveillance, but resistance determinants remain distributed across resources with different scopes, structures, and annotations. We developed PanRes, a curated resistance database of 11,717 genes integrating acquired and latent determinants of antibiotic, biocide, and metal resistance within a unified ontology. We predicted representative protein structures and clustered them by structural similarity, grouping proteins into 598 structurally conserved clusters coherent despite sequence divergence. Their structure-guided alignments were used to build Hidden Markov Models (HMMs) for remote homology search. In wastewater metagenomes from seven European cities, PanRes 3D-based HMMs expanded detection beyond high-confidence BLAST, with 35.2% of retained hits identified only by the HMMs and generally showing greater divergence from known proteins. For beta-lactamases, several proteins retained beta-lactamase-like folds and catalytic geometry despite weak sequence similarity. PanRes is available through an interactive web platform (https://panres.rambio.dk/), a structure-informed resource for exploring the whole resistome.

bioinformatics↗

Calibrating for absolute microbiome abundances without spike-ins

Metagenomics is a widely used approach in microbiome research. However, a major limitation of metagenomic datasets is their compositional nature, which prevents direct quantification of absolute abundances and complicates cross-sample comparisons. Existing strategies for absolute quantification typically require additional experiments or spike-in controls. Here, we introduce the MetaGenome Calibrator (MGCalibrator), a new tool that enables spike-in free, absolute abundance estimation based on routine DNA concentration measurements. We validated the accuracy of absolute abundances obtained with MGCalibrator against qPCR for 5 targets. Our results show a strong correlation with qPCR data, indicating that MGCalibrator enables qPCR-like trend analyses. For Bacteroides dorei, the estimated abundances were highly similar between the two methods (r2 = 0.98, y = 1.00x). For other targets like crAssphage or the bacterial 16S rRNA gene, qPCR values were underrepresented by a factor of 7 or overrepresented by a factor of 4. Benchmarking with synthetic microbiome data demonstrated that our method accurately determines copy numbers in sequencing datasets, and application to whole-cell mock community samples produced expected values based on known extraction biases. In an extraction-bias-free experiment, MGCalibrator accurately quantified genome copy numbers within a twofold range in 98% of cases and determined 16S rRNA gene copies within 1.6-fold or less. Finally, we applied MGCalibrator to track temporal trends in antibiotic resistance genes (ARGs) in wastewater treatment plants in two Dutch provincial capitals. We observed an overall increase in ARGs--such as sul2 in Utrecht and qnrS5 in Houtrust--likely driven by rising bacterial loads. Our findings demonstrate that MGCalibrator provides robust calibration of metagenomic data, paving the way for metagenomics to play a central role in future surveillance by enabling trend analysis across thousands of genetic targets, similar to the capabilities of qPCR for individual genes. The source code and documentation for MGCalibrator are available at github.com/NimroddeWit/MGCalibrator.

microbiology↗

Data mining antibody sequences for database searching in bottom-up proteomics

Mass spectrometry (MS)-based proteomics allows identifying and quantifying thousands of proteins but suffers from challenges when measuring human antibodies due to their vast variety. The mainly used bottom-up proteomics approaches rely on database searches that compare experimental values of peptides and their fragments to theoretical values derived from protein sequences in a database. While the human body can produce millions of distinct antibodies, the current databases for human antibodies such as UniProtKB/Swiss-Prot are limited to only 1095 sequences (as of 2024 Jan). This limitation may hinder the identification of new antibodies using mass spectrometry. Therefore, extending the database for mass spectrometry is an important task for discovering new antibodies. Recent genomic studies have compiled millions of human antibody sequences publicly accessible through the Observed Antibody Space (OAS) database. However, this data has yet to be exploited to confirm the presence of these antibodies. In this study, we adopted this extensive collection of antibody sequences for conducting efficient database searches in publicly available proteomics data with a focus on the SARS-CoV-2 disease. Thirty million heavy antibody sequences from 146 SARS-CoV-2 patients in the OAS database were digested in silico to obtain 18 million unique peptides. These peptides were then used to create new databases for bottom-up proteomics. We used those databases for searching new antibody peptides in publicly available SARS-CoV-2 human plasma samples in the Proteomics Identification Database (PRIDE). This approach avoids false positives in antibody peptide identification as confirmed by searching against negative controls (brain samples) and employing different database sizes. We show that the found sequences provide valuable information to distinguish diseased from healthy and expect that the newly discovered antibody peptides can be further employed to develop therapeutic antibodies. The method will be broadly applicable to find characteristic antibodies for other diseases.

bioinformatics↗